Work

ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor-positive breast cancer.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.18_suppl.lba513

Authors: M. J. Ellis, G. Babiera, G. W. Unzeitig, P. K. Marcom, J. M. Guenther, F. K. Deshryver, D. C. Allred, V. Suman, K. Hunt, J. A. Olson

Institutions: Good Samaritan Hospital, Mayo Clinic, The University of Texas MD Anderson Cancer Center, Doctors Hospital of Laredo, Duke Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2241503054

Cites:

Cited by: 22

Related to: 10